Cubist Systematic Strategies, LLC Dexcom Inc Put Options Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $3.32 Million - $6.01 Million	-51,800 Reduced 59.82%	34,800 $2.33 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $12.4 Million - $15.8 Million	-112,500 Reduced 56.5%	86,600 $9.82 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $1.43 Million - $1.75 Million	12,500 Added 6.7%	199,100 $27.6 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $11.2 Million - $18.5 Million	148,700 Added 392.35%	186,600 $23.2 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $2.21 Million - $3.54 Million	25,700 Added 210.66%	37,900 $3.54 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $202,446 - $235,763	1,800 Added 17.31%	12,200 $1.57 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $208,000 - $245,840	2,000 Added 23.81%	10,400 $1.21 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $5.65 Million - $8.16 Million	-66,500 Reduced 88.79%	8,400 $951,000
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $274,860 - $339,048	-3,600 Reduced 4.59%	74,900 $6.03 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $5.34 Million - $10.4 Million	78,500 New	78,500 $5.85 Million

1,023

353M

5.51M

5.61M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.